» Authors » David McCarty

David McCarty

Explore the profile of David McCarty including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 388
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Finch P, Ndovie M, Rashid M, McCarty D
Trop Doct . 2025 Feb; :494755251318077. PMID: 39925039
A low-cost device capable of recording a full 12-lead electrocardiogram (ECG) is described using a commercially available analogue front end (ADS1293) and a microprocessor (ESP32) transmitting a signal by Bluetooth...
2.
Spencer S, Malowa F, McCarty D, Joekes E, Phulusa J, Chinoko B, et al.
Wellcome Open Res . 2024 Aug; 9:205. PMID: 39157428
Background: Hospital admission due to breathlessness carries a significant burden to patients and healthcare systems, particularly impacting people in low-income countries. Prompt appropriate treatment is vital to improve outcomes, but...
3.
Branella G, Lee J, Okalova J, Parwani K, Alexander J, Arthuzo R, et al.
Front Immunol . 2023 Nov; 14:1294555. PMID: 38022523
The application of immunotherapies such as chimeric antigen receptor (CAR) T therapy or bi-specific T cell engager (BiTE) therapy to manage myeloid malignancies has proven more challenging than for B-cell...
4.
Bakar S, Hayman S, McCarty D, Thain A, Mclellan A, Wagner C, et al.
Heart Lung Circ . 2021 Aug; 31(2):194-198. PMID: 34332889
Introduction: Hypertrophic cardiomyopathy (HCM) is often associated with ischaemia despite lack of focal epicardial coronary stenosis. Our aim was to assess invasive coronary microvascular circulation and correlate findings with echocardiography....
5.
Tadros R, Francis C, Xu X, Vermeer A, Harper A, Huurman R, et al.
Nat Genet . 2021 Jan; 53(2):128-134. PMID: 33495596
The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are leading causes of sudden death and heart failure in young, otherwise healthy, individuals. We conducted genome-wide association studies and...
6.
Nfonsam L, Huang L, Carson N, McGowan-Jordan J, Beaulieu Bergeron M, Goobie S, et al.
Mol Genet Genomic Med . 2019 Oct; 8(1):e951. PMID: 31568709
Background: Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy (LVH) in the absence of predisposing cardiovascular conditions. Pathogenic variants in at least 16 cardiac sarcomeric genes have been implicated...
7.
Modi S, Yee R, Scholl D, Stirrat J, Wong J, Lydell C, et al.
Int J Cardiovasc Imaging . 2017 May; 33(10):1653. PMID: 28470434
No abstract available.
8.
Morant K, Mikami Y, Nevis I, McCarty D, Stirrat J, Scholl D, et al.
Int J Cardiovasc Imaging . 2017 Apr; 33(8):1201-1211. PMID: 28391581
We sought to examine whether elongation of the mitral valve leaflets in patients with hypertrophic cardiomyopathy (HCM) is synergistic to septal wall thickness (SWT) in the development of left ventricular...
9.
Modi S, Yee R, Scholl D, Stirrat J, Wong J, Lydell C, et al.
Int J Cardiovasc Imaging . 2017 Mar; 33(9):1433-1442. PMID: 28357725
Cardiac Resynchronization Therapy (CRT) fails to provide benefit in up to one-third of patients. Maximizing the geographic separation of right and left ventricular pacing lead sites has been suggested as...
10.
Blissett S, Morrison D, McCarty D, Sibbald M
Med Educ . 2017 Feb; 51(4):432-441. PMID: 28150431
Context: Making a diagnosis can be difficult for learners as they must integrate multiple clinical variables. Diagnostic schemes can help learners with this complex task. A diagnostic scheme is an...